Besides, KMT2C is regarded as a tumor suppressor, and deletion of this gene is correlated with unfavorable prognosis of breast cancer [48], acute myeloid leukemia [49], and gastric adenocarcinoma [50]. This evidence concerns the gene KMT2C and breast carcinoma.